Logo image of FNGR

FINGERMOTION INC (FNGR) Stock Fundamental Analysis

NASDAQ:FNGR - Nasdaq - US31788K1088 - Common Stock - Currency: USD

1.86  +0.04 (+1.92%)

After market: 1.92 +0.06 (+3.23%)

Fundamental Rating

2

FNGR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 21 industry peers in the Wireless Telecommunication Services industry. FNGR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FNGR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FNGR had negative earnings in the past year.
FNGR had a negative operating cash flow in the past year.
FNGR had negative earnings in each of the past 5 years.
In the past 5 years FNGR always reported negative operating cash flow.
FNGR Yearly Net Income VS EBIT VS OCF VS FCFFNGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

FNGR's Return On Assets of -16.96% is on the low side compared to the rest of the industry. FNGR is outperformed by 85.71% of its industry peers.
FNGR has a Return On Equity of -56.26%. This is amonst the worse of the industry: FNGR underperforms 85.71% of its industry peers.
Industry RankSector Rank
ROA -16.96%
ROE -56.26%
ROIC N/A
ROA(3y)-36.86%
ROA(5y)-44.25%
ROE(3y)-62.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FNGR Yearly ROA, ROE, ROICFNGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

FNGR has a Gross Margin of 6.39%. This is amonst the worse of the industry: FNGR underperforms 90.48% of its industry peers.
In the last couple of years the Gross Margin of FNGR has declined.
The Profit Margin and Operating Margin are not available for FNGR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.94%
GM growth 5Y-14.14%
FNGR Yearly Profit, Operating, Gross MarginsFNGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

FNGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FNGR has more shares outstanding
Compared to 5 years ago, FNGR has more shares outstanding
There is no outstanding debt for FNGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FNGR Yearly Shares OutstandingFNGR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
FNGR Yearly Total Debt VS Total AssetsFNGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

FNGR has an Altman-Z score of 2.23. This is not the best score and indicates that FNGR is in the grey zone with still only limited risk for bankruptcy at the moment.
FNGR has a Altman-Z score of 2.23. This is amongst the best in the industry. FNGR outperforms 90.48% of its industry peers.
FNGR has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
FNGR has a better Debt to Equity ratio (0.17) than 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 2.23
ROIC/WACCN/A
WACC8.85%
FNGR Yearly LT Debt VS Equity VS FCFFNGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

FNGR has a Current Ratio of 1.42. This is a normal value and indicates that FNGR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of FNGR (1.42) is better than 66.67% of its industry peers.
FNGR has a Quick Ratio of 1.42. This is a normal value and indicates that FNGR is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.42, FNGR belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
FNGR Yearly Current Assets VS Current LiabilitesFNGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for FNGR have decreased by -5.67% in the last year.
FNGR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.91%.
Measured over the past years, FNGR shows a very strong growth in Revenue. The Revenue has been growing by 89.36% on average per year.
EPS 1Y (TTM)-5.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.95%
Revenue 1Y (TTM)-16.91%
Revenue growth 3Y28.98%
Revenue growth 5Y89.36%
Sales Q2Q%38.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y143.71%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year69.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FNGR Yearly Revenue VS EstimatesFNGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
FNGR Yearly EPS VS EstimatesFNGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2024 2025 0 -0.05 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

FNGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 60.78, the valuation of FNGR can be described as expensive.
Based on the Price/Forward Earnings ratio, FNGR is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
FNGR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.38.
Industry RankSector Rank
PE N/A
Fwd PE 60.78
FNGR Price Earnings VS Forward Price EarningsFNGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FNGR Per share dataFNGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

FNGR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FNGR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FINGERMOTION INC

NASDAQ:FNGR (4/25/2025, 8:08:13 PM)

After market: 1.92 +0.06 (+3.23%)

1.86

+0.04 (+1.92%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)01-21 2025-01-21
Earnings (Next)05-27 2025-05-27/amc
Inst Owners3.13%
Inst Owner Change0%
Ins Owners5.71%
Ins Owner Change0%
Market Cap106.28M
Analysts82.86
Price TargetN/A
Short Float %6.08%
Short Ratio9.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 60.78
P/S 3.17
P/FCF N/A
P/OCF N/A
P/B 11.04
P/tB 11.05
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0.03
Fwd EY1.65%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.59
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.96%
ROE -56.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.39%
FCFM N/A
ROA(3y)-36.86%
ROA(5y)-44.25%
ROE(3y)-62.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.94%
GM growth 5Y-14.14%
F-Score2
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.23%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 2.23
F-Score2
WACC8.85%
ROIC/WACCN/A
Cap/Depr(3y)55.74%
Cap/Depr(5y)233.45%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.95%
EPS Next Y143.71%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.91%
Revenue growth 3Y28.98%
Revenue growth 5Y89.36%
Sales Q2Q%38.99%
Revenue Next Year69.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.77%
OCF growth 3YN/A
OCF growth 5YN/A